First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials

FOXFIRE trial investigators; SIRFLOX trial investigators; FOXFIRE-Global trial investigators; SIRFLOX trial investigators; FOXFIRE-Global trial investigators; FOXFIRE-Global trial investigators

doi:10.1016/S1470-2045(17)30457-6

First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials

FOXFIRE trial investigators
, SIRFLOX trial investigators
, FOXFIRE-Global trial investigators
, SIRFLOX trial investigators
, FOXFIRE-Global trial investigators
, FOXFIRE-Global trial investigators

Miami Cancer Institute

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	1159-1171
Number of pages	13
Journal	The Lancet Oncology
Volume	18
Issue number	9
DOIs	https://doi.org/10.1016/S1470-2045(17)30457-6
State	Published - Sep 1 2017

ASJC Scopus Subject Areas

Oncology

Access to Document

10.1016/S1470-2045(17)30457-6

Cite this

FOXFIRE trial investigators, SIRFLOX trial investigators, FOXFIRE-Global trial investigators, SIRFLOX trial investigators, FOXFIRE-Global trial investigators, & FOXFIRE-Global trial investigators (2017). First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials. The Lancet Oncology, 18(9), 1159-1171. https://doi.org/10.1016/S1470-2045(17)30457-6

First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials. / FOXFIRE trial investigators; SIRFLOX trial investigators; FOXFIRE-Global trial investigators et al.
In: The Lancet Oncology, Vol. 18, No. 9, 01.09.2017, p. 1159-1171.

Research output: Contribution to journal › Article › peer-review

FOXFIRE trial investigators, SIRFLOX trial investigators, FOXFIRE-Global trial investigators, SIRFLOX trial investigators, FOXFIRE-Global trial investigators & FOXFIRE-Global trial investigators 2017, 'First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials', The Lancet Oncology, vol. 18, no. 9, pp. 1159-1171. https://doi.org/10.1016/S1470-2045(17)30457-6

FOXFIRE trial investigators, SIRFLOX trial investigators, FOXFIRE-Global trial investigators, SIRFLOX trial investigators, FOXFIRE-Global trial investigators, FOXFIRE-Global trial investigators. First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials. The Lancet Oncology. 2017 Sep 1;18(9):1159-1171. doi: 10.1016/S1470-2045(17)30457-6

FOXFIRE trial investigators ; SIRFLOX trial investigators ; FOXFIRE-Global trial investigators et al. / First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global) : a combined analysis of three multicentre, randomised, phase 3 trials. In: The Lancet Oncology. 2017 ; Vol. 18, No. 9. pp. 1159-1171.

@article{3bac71216ae24862911d05b7740f7dab,

title = "First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials",

author = "\{FOXFIRE trial investigators\} and \{SIRFLOX trial investigators\} and \{FOXFIRE-Global trial investigators\} and \{SIRFLOX trial investigators\} and \{FOXFIRE-Global trial investigators\} and \{FOXFIRE-Global trial investigators\} and Wasan, \{Harpreet S.\} and Peter Gibbs and Sharma, \{Navesh K.\} and Julien Taieb and Volker Heinemann and Jens Ricke and Marc Peeters and Michael Findlay and Andrew Weaver and Jamie Mills and Charles Wilson and Richard Adams and Anne Francis and Joanna Moschandreas and Virdee, \{Pradeep S.\} and Peter Dutton and Sharon Love and Val Gebski and Alastair Gray and Andrew Bateman and Claire Blesing and Ewan Brown and Ian Chau and Sebastian Cummins and David Cunningham and Stephen Falk and Maher Hadaki and Marcia Hall and Tamas Hickish and Joanne Hornbuckle and Fiona Lofts and Sarah Lowndes and Astrid Mayer and Matthew Metcalfe and Gary Middleton and Amir Montazeri and Rebecca Muirhead and Andreas Polychronis and Colin Purcell and Paul Ross and Sharma, \{Ricky A.\} and Liz Sherwin and David Smith and Rubin Soomal and Daniel Swinson and Axel Walther and Greg Wilson and Pradip Amin and Michael Chuong and Adeel Kaiser",

note = "Publisher Copyright: {\textcopyright} 2017 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license",

year = "2017",

month = sep,

day = "1",

doi = "10.1016/S1470-2045(17)30457-6",

language = "English",

volume = "18",

pages = "1159--1171",

journal = "The Lancet Oncology",

issn = "1470-2045",

number = "9",

}

TY - JOUR

T1 - First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global)

T2 - a combined analysis of three multicentre, randomised, phase 3 trials

AU - FOXFIRE trial investigators

AU - SIRFLOX trial investigators

AU - FOXFIRE-Global trial investigators

AU - SIRFLOX trial investigators

AU - FOXFIRE-Global trial investigators

AU - Wasan, Harpreet S.

AU - Gibbs, Peter

AU - Sharma, Navesh K.

AU - Taieb, Julien

AU - Heinemann, Volker

AU - Ricke, Jens

AU - Peeters, Marc

AU - Findlay, Michael

AU - Weaver, Andrew

AU - Mills, Jamie

AU - Wilson, Charles

AU - Adams, Richard

AU - Francis, Anne

AU - Moschandreas, Joanna

AU - Virdee, Pradeep S.

AU - Dutton, Peter

AU - Love, Sharon

AU - Gebski, Val

AU - Gray, Alastair

AU - Bateman, Andrew

AU - Blesing, Claire

AU - Brown, Ewan

AU - Chau, Ian

AU - Cummins, Sebastian

AU - Cunningham, David

AU - Falk, Stephen

AU - Hadaki, Maher

AU - Hall, Marcia

AU - Hickish, Tamas

AU - Hornbuckle, Joanne

AU - Lofts, Fiona

AU - Lowndes, Sarah

AU - Mayer, Astrid

AU - Metcalfe, Matthew

AU - Middleton, Gary

AU - Montazeri, Amir

AU - Muirhead, Rebecca

AU - Polychronis, Andreas

AU - Purcell, Colin

AU - Ross, Paul

AU - Sharma, Ricky A.

AU - Sherwin, Liz

AU - Smith, David

AU - Soomal, Rubin

AU - Swinson, Daniel

AU - Walther, Axel

AU - Wilson, Greg

AU - Amin, Pradip

AU - Chuong, Michael

AU - Kaiser, Adeel

PY - 2017/9/1

Y1 - 2017/9/1

UR - https://www.scopus.com/pages/publications/85028032555

UR - https://www.scopus.com/pages/publications/85028032555#tab=citedBy

U2 - 10.1016/S1470-2045(17)30457-6

DO - 10.1016/S1470-2045(17)30457-6

M3 - Article

C2 - 28781171

AN - SCOPUS:85028032555

SN - 1470-2045

VL - 18

SP - 1159

EP - 1171

JO - The Lancet Oncology

JF - The Lancet Oncology

IS - 9

ER -

First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials

ASJC Scopus Subject Areas

Access to Document

Other files and links

Cite this